Literature DB >> 19086434

[Clinical comparison of male and female patients with pulmonary disease caused by Mycobacterium avium complex (P-MAC)].

Kozo Morimoto1, Rie Ishikawa, Atsuko Moriya, Aiko Masunaga, Hiroyuki Kamiya, Tsunehiro Ando, Souichiro Ikushima, Masaru Oritsu.   

Abstract

OBJECTIVES: The objective of this study was to clarify clinical feature of Pulmonary Mycobacterium avium complex disease (P-MAC).
METHOD: The present study was performed in 120 patients with P-MAC diagnosed during the period from January 2000 to March 2007. We divided P-MAC patients into four groups by the clinical disease type and gender, and retrospectively examined the clinical characteristics.
RESULTS: The subjects were 15 male (NB-M) and 71 female (NB-F) patients with nodular bronchiectatic disease (NB), and 24 male (FC-M) and 10 female (FC-F) patients with fibrocavitary disease (FC). The average age was lowest in the NB-F group (58.0 yrs), and highest in the FC-M group (65.8 yrs). There were 17 patients in the FC-M group and only two patients in the FC-F group with a history of smoking. The average body mass index (BMI) was 16.9, with the lowest value in the FC-F group. In the FC-M group, most of the patients had underlying pulmonary disease, whereas in the FC-F group, only four patients had underlying old pulmonary tuberculosis. The average anterior-posterior dimension was 75.2 mm, being lowest in the FC-F group, and more than 90 mm in the other groups. The proportion of refractory cases was lowest in the NB-M group.
CONCLUSION: We thought that we were able to clarify characteristics of patients with disease caused by MAC by analyzing the types of the disease separately in men and women.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19086434

Source DB:  PubMed          Journal:  Kekkaku        ISSN: 0022-9776


  1 in total

1.  Comparison of clinical characteristics of patients with Mycobacterium avium complex disease by gender.

Authors:  Y Ikuyama; A Ushiki; J Akahane; M Kosaka; Y Kitaguchi; K Urushihata; M Yasuo; H Yamamoto; M Hanaoka
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.